EVOKE PHARMA INC - COM (EVOK)

CUSIP: 30049G104

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Equity / COM
Total 13F shares
1,278,062
Share change
-443,736
Total reported value
$798,000
Price per share
$0.62
Number of holders
17
Value change
-$444,915
Number of buys
6
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 30049G104?
CUSIP 30049G104 identifies EVOK - EVOKE PHARMA INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EVOKE PHARMA INC - COM (EVOK) as of Q2 2019

As of 30 Jun 2019, EVOKE PHARMA INC - COM (EVOK) was held by 17 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,278,062 shares. The largest 10 holders included STATE TREASURER STATE OF MICHIGAN, VANGUARD GROUP INC, Virtu Financial LLC, GEODE CAPITAL MANAGEMENT, LLC, Creative Planning, CITADEL ADVISORS LLC, BlackRock Inc., CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and NORTHERN TRUST CORP. This page lists 17 institutional shareholders reporting positions in this security for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.